Orthopaedics

3D Imaging Guidance to Reverse Growth Plate Injury

Discover how Cincinnati Children’s uses 3D imaging to improve precision and outcomes in pediatric physeal bar excision surgery.

Pulmonary Medicine

Addressing Scholastic and Mental Health Needs in Patients with Cystic Fibrosis

Discover how Cincinnati Children’s CF WELL program is transforming care for children with cystic fibrosis—addressing educational and mental health needs alongside clinical advances.

Cancer and Blood Diseases

Advancements Bring New Hope for Sickle Cell Disease

A Phase II clinical trial conducted in Ghana suggests that hydroxyurea — already a treatment offered for the most common form of sickle cell disease — also shows benefits for those with the hemoglobin SC (HbSC) variant of the condition.

Heart

Advancing Catheter Ablation for CHD Patients

Cincinnati Children’s is advancing catheter ablation techniques to treat arrhythmias in patients with congenital heart disease.

Heart

AI and Flight Plans Unite to Improve Patient Outcomes

Cincinnati Children’s explores AI-powered Flight Plans to enhance decision-making and outcomes in pediatric heart care through data-driven, cloud-based tools.

Perinatal

AI Drives Discovery in Pulmonary Biology

Scientists are advancing lung research using AI and computational genomics to decode biology’s multidimensional complexity.

Fetal Care

Anesthesia Strategies for Fetoscopic Myelomeningocele (MMC) Repair

Study finds no link between maternal temperature and fetal heart rate during fetoscopic myelomeningocele (MMC) repairs, guiding anesthetic improvements.

Neurology and Neurosurgery

Cell Therapy Offers Hope for Duchenne Muscular Dystrophy Patients

Cincinnati Children’s leads phase 3 trials of CAP-1002, a cell therapy showing promise for late-stage Duchenne muscular dystrophy patients with limited treatment options.

Diabetes and Endocrinology

Cell Therapy Shows Hope for Limb Ischemia Care

Cincinnati Children’s researchers uncover CD271+ cells in adipose tissue with strong angiogenic properties—offering a promising new approach to treating critical limb ischemia through regenerative cell therapy.

Cancer and Blood Diseases

Cincinnati Children’s Adds New Cancer and Blood Disease Faculty

The Cancer and Blood Diseases Institute recently welcomed 10 new faculty members, expanding our solid tumor, leukemia, onco-critical care, bone marrow transplantation, immune deficiency, and hematology programs.